2m 2m 2m 2m 2m 2m 2m
PMV PHARMA (PMVP)
NASDAQ
$1.30-$0.06 (-4.41%)
Price as of Oct 22, 2026 7:30 PM EDT- $72.7MMarket Cap
- -11.69%1-Year Change
- BiotechnologyIndustry
PMV PHARMA (PMVP)
$1.30-$0.06 (-4.41%)
PMVP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.36 | ||
Change | -$0.03 (-2.16%) | ||
Open | $1.37 | ||
High | $1.41 | ||
Low | $1.35 | ||
Previous Close | $1.39 | ||
Volume | 236,573 | ||
30-Day Average Volume | 787,937 | ||
1-Week Change | 9.68% | ||
1-Month Change | -7.80% | ||
1-Year Change | -11.69% | ||
3-Year Change | -8.72% | ||
5-Year Change | -94.13% | ||
Fundamentals | |||
Shares Outstanding | 53.5M | ||
Total Assets | $82.1M | ||
Market Cap | $72.7M | ||
Enterprise Value | $60.9M | ||
Period: QTR TTM FY | |||
Revenue | $788,000.00 | ||
Net Income | -$18.1M | ||
Free Cash Flow | -$14.6M | ||
EBIT | -$18.1M | ||
EBITDA | -$18.1M | ||
Net Working Capital | $70.8M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 77 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | N/A | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue